Genome Web Breaking News
- Agendia Settles Allegations of Medicare Fraud for $8.25M
- Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020
- Type 2 Diabetes Associated With Altered Daily Gut Microbe Oscillations
- In Brief This Week: Genomics England, Centogene, Cergentis, and More
- New Products Posted to GenomeWeb: Twist Bioscience, NeoGenomics, Flagship Biosciences
Stat
- Opinion: People in mental health crises need help, not handcuffs
- Public health experts urge socially distant Fourth of July celebrations, as the coronavirus surges across the U.S.
- Listen: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life
- Trial of Moderna Covid-19 vaccine delayed, investigators say, but July start still possible
- STAT Plus: Alexion to pay $21 million for failing to record bribes paid to doctors in other countries
NYT science news
Xconomy news
- MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy
- Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients
- Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing
- Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration
- BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity
Fierce Biotech
- Moderna shares hit by COVID-19 vax trial delay report, but biotech says July start still on track
- Kroger secures FDA authorization for at-home coronavirus test kit
- MEI Pharma, Helsinn Group cut losses, ditch phase 3 partnered cancer test for pracinostat
- Chutes & Ladders—Novavax taps Machielse to head manufacturing in lead up to approvals
- Sarepta bags drug to fully unlock DMD gene therapy opportunity
Fierce Medical Devices
- Kroger secures FDA authorization for at-home coronavirus test kit
- Kardium nets atrial fibrillation CE Mark for its spherical heart ablation catheter
- Evidation nets $45M to expand from virtual research into virtual treatment
- Twist Bioscience launches research panel for screening COVID-19, other respiratory viruses
- Abbott, Tandem finalize course to integrate diabetes tech